Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited (CLVLY) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CLVLY · as of Jun 9, 2026
Key Statistics
Explore Clinuvel Pharmaceuticals Limited Data
clvly stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
clvly competitorsCLVLY
AVCTF
BOVNF
CMVLF
CYDY
FGHQFStock Performance
Full HistoryAbout Clinuvel Pharmaceuticals Limited
Clinuvel Pharmaceuticals Limited is a biopharmaceutical firm dedicated to creating and marketing therapies for individuals worldwide grappling with genetic, metabolic, and severe medical conditions, o…
what is clinuvel pharmaceuticals limited · clvly stock overview · clinuvel pharmaceuticals limited company profile · who is clinuvel pharmaceuticals limited ceo · clvly OTC · clinuvel pharmaceuticals limited headquarters · clinuvel pharmaceuticals limited business segments
About Stock Overview & Key Data
Clinuvel Pharmaceuticals Limited (CLVLY) is a Healthcare company in the Biotechnology industry, listed on OTC since Jan 30, 2008. As of the latest trading session, CLVLY stock price is $6.73, with a market capitalization of $339.2M. The stock has returned +0.41% over the past 12 months and -20.66% year-to-date.
In fiscal year 2025, Clinuvel Pharmaceuticals Limited reported revenue of $95.0M. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Clinuvel Pharmaceuticals Limited (CLVLY) stock price is $6.73. The stock is traded on OTC under the ticker symbol CLVLY. The 52-week range is $5.98 – $9.00.